2-((2-ethyl-1H-imidazol-1-yl)methyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

ID: ALA3809759

PubChem CID: 127043388

Max Phase: Preclinical

Molecular Formula: C20H21N3

Molecular Weight: 303.41

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1nccn1Cc1ccc2c(c1)CCc1ccccc1N2

Standard InChI:  InChI=1S/C20H21N3/c1-2-20-21-11-12-23(20)14-15-7-10-19-17(13-15)9-8-16-5-3-4-6-18(16)22-19/h3-7,10-13,22H,2,8-9,14H2,1H3

Standard InChI Key:  AUYHJAUDTJFUMB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.8722   -1.3706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1246    1.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6509    1.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2272   -0.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5854    0.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0183    1.1214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1241    0.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7970   -1.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3486   -1.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7943    0.7632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4672   -0.7164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5730   -1.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0215   -1.2460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3330    0.1557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2272    1.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5661    0.5103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6483   -0.5295    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8147   -1.5769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1096   -0.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7734   -2.6566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4248   -1.9999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7579    1.0977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9544    1.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11  1  1  0
  1  4  1  0
 10  2  1  0
  5  3  1  0
  2  3  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 16  1  0
 16 17  1  0
 17 21  1  0
 20 18  1  0
 18 19  2  0
 19 17  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3809759

    ---

Associated Targets(Human)

GPR4 Tchem G-protein coupled receptor 4 (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 303.41Molecular Weight (Monoisotopic): 303.1735AlogP: 4.34#Rotatable Bonds: 3
Polar Surface Area: 29.85Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.91CX LogP: 4.63CX LogD: 4.52
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: -1.21

References

1. Fukuda H, Ito S, Watari K, Mogi C, Arisawa M, Okajima F, Kurose H, Shuto S..  (2016)  Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction.,  (5): [PMID:27190599] [10.1021/acsmedchemlett.6b00014]

Source